Chadi Nabhan, MD, MBA, FACP is a board-certified Hematologist and Medical Oncologist who practices in diverse healthcare settings. He is the creator and host of his own podcast, “Healthcare Unfiltered.”
He joined Caris Life Sciences in April 2020 as Chairman of its Precision Oncology Alliance (POA). He provides medical and scientific leadership to the collaborative network of leading cancer centers across the country that demonstrates a commitment to precision medicine.
Hematology and Medical Oncology
Hematology and Medical Oncology is one of the fastest-growing fields in medicine. New technology and drug advancements have made it possible to provide personalized, effective treatments for blood cancers.
Hemology and Medical Oncologists use blood tests, such as a complete blood count (CBC), to identify any neoplastic changes in the body, which may indicate the presence of a blood cancer. The CBC also shows how many different types of blood cells are present in the bloodstream.
Hematologists treat a variety of blood disorders, such as anemia and sickle cell disease. They also care for patients with cancers of the blood-related systems including leukemia and lymphoma. Hematologists work closely with oncologists to develop treatment plans for these patients.
Lymphoid Malignancies
Lymphoid malignancies are cancers of the lymphatic system (the lymph glands that are found throughout your body). There are around 60 different types, which vary in how fast they grow and how sick people feel.
Most people with lymphoma have no known cause, but there are some people who are at a higher risk of developing it. This can include those who have HIV or take immune system-suppressing drugs after an organ transplant.
There are a number of different treatments for lymphoma, depending on the type and how advanced the cancer is. Many are very effective and can cure most patients.
Genitourinary Cancers
Chadi Nabhan, MD, MBA, FACP is a medical oncologist with a broad interest in lymphoid malignancies and genitourinary cancers. He is also a health care economist, the host of his own podcast, and a medical writer.
He has written and produced more than 300 peer-reviewed papers, is a fellow of the American College of Physicians, and is on active medical licenses in five states. He is a board-certified hematologist and medical oncologist and has served as an expert witness in Monsanto trials for non-Hodgkin’s lymphoma.
Currently, physicians and patients are divided about whether to change the name for prostate cancer with Gleason score 6 from cancer to noncancer. Those who support the change say it will help reduce anxiety, lead to more targeted treatment and avoid unnecessary side effects, and may help improve life insurance coverage.
Value-Based Care
Value-Based Care is a new healthcare delivery system in which providers are paid based on the health outcomes they achieve. This model aims to reduce costs, improve patient outcomes, and increase efficiency in the health system.
When value-based care works as intended, patients face fewer doctor’s visits, medical tests, and procedures, and spend less on prescription medications. This helps them recover more quickly from illness and injury and avoid chronic disease.
Similarly, providers and their teams can spend more time helping their patients feel better, rather than spending their time on paperwork or other administrative tasks. This can help combat physician burnout and promote more positive, team-based patient relationships.
In addition, VBC programs can focus on the social determinants of health, such as community, environment, and socioeconomic factors. This is important for population health management and can lead to improved health outcomes, lower costs, and a healthier society.
